Eupraxia Pharmaceuticals 株価情報 (NASDAQ: EPRX)

最新ニュース Eupraxia Pharmaceuticals (NASDAQ:EPRX) 株価情報

Eupraxia Pharmaceuticals

Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to existing pharmaceuticals. Its product EP-104 is used for the treatment of osteoarthritis and eosinophilic esophagitis symptoms. The company leverages its proprietary Diffusphere technology to optimize drug delivery for applications with unmet medical needs.

Eupraxia Pharmaceuticals Inc. - Common Stock

Eupraxia Pharmaceuticals Inc

Eupraxia Pharmaceuticals Inc Ordinary Shares

Rosenblatt analyst Chris Brendler maintains HIVE Digital Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HIVE#NASDAQ">HIVE</a>) with a Buy and lowers the price target from $5.5 to $5.

News

Price Target

Analyst Ratings

HIVE

Rosenblatt Maintains Buy on HIVE Digital Technologies, Lowers Price Target to $5

On Thursday, June 26, U.S. markets closed higher as easing geopolitical tensions and supportive economic data boosted hopes for Federal Reserve rate cuts this year. Major indexes advanced in a broad rally, edging the S&amp;P 500 and Nasdaq closer to record highs.
Bank stocks led gains after a regulatory proposal, while Fed officials signaled openness to easing. Mixed economic signals, including weak consumer spending and strong orders, fueled speculation about the timing of rate cuts.
According to economic data, the U.S. first-quarter GDP was revised down to -0.5% from -0.2%, driven by a larger trade deficit from weaker exports. However, May factory orders jumped 16.4% to $343.6 billion, the biggest monthly gain since 2014, far exceeding expectations. Weekly jobless claims dropped by 10,000 to 236,000, defying forecasts of no change and signaling ongoing strength in the labor market.
Most S&amp;P 500 sectors rose, led by communication services, consumer discretionary, and energy. Real estate and consumer staples declined.
The Dow rose 0.94% to 43,386.84, the S&amp;P 500 was up 0.80% at 6,141.02, and the Nasdaq gained 0.97% to 20,167.91.
<h2 class="wp-block-heading">Asia Markets Today</h2>
On Friday, Japan&#8217;s Nikkei 225 closed 1.42% higher at 40,145.50, led by gains in the Real Estate, Banking, and Textile sectors.
Australia&#8217;s S&amp;P/ASX 200 was down 0.43% at 8,514.20, led by losses in the Financials, Healthcare, and A-REITs sectors.
India&#8217;s Nifty 50 was up 0.37% at 25,640.40, and the Nifty 500 gained 0.44% to 23,621.45.
China&#8217;s Shanghai Composite was down 0.70% at 3,424.23, and Shanghai Shenzhen CSI 300 fell 0.61% to 3,921.76.
Hong Kong&#8217;s Hang Seng closed the session 0.17% lower at 24,284.15.
<h2 class="wp-block-heading">Eurozone at 05:45 AM ET</h2>
The European STOXX 50 index was up 0.97%.
Germany&#8217;s DAX index gained 0.83%.
France&#8217;s CAC 40 rose 1.41%.
U.K.&#8217;s FTSE 100 index traded higher by 0.54%.
European stocks rose on U.S.-China trade progress and Middle East ceasefire optimism.
<h2 class="wp-block-heading">Commodities at 05:45 AM ET</h2>
Crude Oil WTI was trading higher by 0.72% at $65.71/bbl, and Brent was up 0.61% at $67.10/bbl.
Oil prices increased Friday but were on track for their biggest weekly drop since March 2023, as easing geopolitical tensions erased risk premiums. Focus shifted back to supply-demand fundamentals, with support from falling inventories and strong Chinese imports.
Natural gas rose 2.75% to $3.623.
Gold traded lower by 1.47% to $3,298.62, Silver fell 2.26% to $35.755, and Copper declined 1.34% to $4.9955.
Gold fell to a near four-week low as the Israel-Iran ceasefire reduced safe-haven demand and investors awaited key U.S. inflation data.
<h2 class="wp-block-heading">U.S. Futures</h2>
At 05:45 AM ET, the Dow Jones futures rose 0.24%, the S&amp;P 500 gained 0.23%, and the Nasdaq 100 was up 0.31%.
<h2 class="wp-block-heading">Forex</h2>
At 05:45 AM ET, the U.S. Dollar Index declined 0.04% to 97.26, USD/JPY was up 0.01% to 144.44, and USD/AUD gained 0.10% to 1.5290.
The U.S. dollar neared multi-year lows as markets priced in deeper rate cuts and a possible dovish Fed chair replacement.
Photo via Shutterstock

Asia

Emerging Markets

Eurozone

Futures

Commodities

Forex

Markets

ADIV

AGOV

ASHR

BBEU

BOIL

CQQQ

PowerShares DBmmodity Index Optimum Yield Diversified Fund

EEMA

FLAX

CurrencyShares British Pound Sterling Trust

IEMG

IEUR

KraneShares Trust KraneShares S&P Pan Asia Dividend Aristocrats Index ETF

KDIV

SPEM

USDU

PowerShares DB US Dollar Index Bullish Fund

Asia Markets Mixed, Europe Advances, Gold And Dollar Slip Further - Global Markets Today While US Slept

Gencor Industries (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GENC#NASDAQ">GENC</a>) reported quarterly earnings of $0.10 per share. This is a 52.38 percent decrease over earnings of $0.21 per share from the same period last year. The company reported $20.921 million in sales this quarter. This is a 0.24 percent increase over sales of $20.871 million the same period last year.

Earnings

GENC

Gencor Industries Q4 EPS $0.10 Down From $0.21 YoY, Sales $20.921M Up From $20.871M YoY

TSBX

Trading Halt: Halted at 7:25:00 a.m. ET - Trading Halt: Halt News Pending

Gencor Industries Says Net Revenue For Year Ended September 30, 2024 Increased 7.7% To $113.2M Million; Gross Profit Margin Was 27.7% In FY24 Compared To 27.6% YoY

NKE: 11% &#x7C; <a href="https://www.benzinga.com/node/46128469">Nike Q4 Earnings: Revenue Beat, EPS Beat, Headwinds Expected To Moderate Moving Forward, Company Playing 'Sport Offense'</a>
&nbsp;
BBLG: 188% &#x7C; <a href="https://www.benzinga.com/node/46136060">Bone Biologics Files USPTO Patent For rhNELL-1 Protein In Bone Regeneration Therapy</a>
&nbsp;
INMB: 130% &#x7C; <a href="https://www.benzinga.com/node/46127302">INmune Bio shares are trading higher after the company revealed top-line results from its MINDFuL Phase 2 trial.</a>

Movers

Trading Ideas

BBLG

INMB

Market-Moving News for June 27th

IPOs

Citigourp Global Markets 2% Protected Notes Linked To The Djia

Reuters Reported Shein To File Confidential Draft Prospectus For Hong Kong IPO; Filing Expected To Be Made By Monday,

HC Wainwright &amp; Co. analyst Douglas Tsao reiterates Crinetics Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRNX#NASDAQ">CRNX</a>) with a Buy and maintains $81 price target.

Reiteration

CRNX

HC Wainwright & Co. Reiterates Buy on Crinetics Pharmaceuticals, Maintains $81 Price Target

Meta rises over 12 points after the alert
<figure class="wp-block-image size-large"><img decoding="async" src="https://contributor-assets.benzinga.com/wp-content/uploads/2025/06/26200942/Screenshot-2025-06-26-at-4.08.16%E2%80%AFPM-1006x1024.png" alt="" class="wp-image-14959" /></figure>
Meta Platforms Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) today experienced a Power Inflow, a significant event for those who follow where smart money goes and value order flow analytics in their trading decisions. 
Today, at 10:07 AM on June 26th, a significant trading signal occurred for Meta Platforms Inc., (META) as it demonstrated a Power Inflow at a price of $240.74. This indicator is crucial for traders who want to know directionally where institutions and so-called "smart money" moves in the market. They see the value of utilizing order flow analytics to guide their trading decisions. The Power Inflow points to a possible uptrend in Meta's stock, marking a potential entry point for traders looking to capitalize on the expected upward movement. Traders with this signal closely watch for sustained momentum in Meta's stock price, interpreting this event as a bullish sign.
Signal description
Order flow analytics, aka transaction or market flow analysis, separate and study both the retail and institutional volume rate of orders (flow). It involves analyzing the flow of buy and sell orders, along with size, timing, and other associated characteristics and patterns, to gain insights and make more informed trading decisions. This particular indicator is interpreted as a bullish signal by active traders.&nbsp;
The Power Inflow occurs within the first two hours of the market open and generally signals the trend that helps gauge the stock's overall direction, powered by institutional activity in the stock, for the remainder of the day.&nbsp;
By incorporating order flow analytics into their trading strategies, market participants can better interpret market conditions, identify trading opportunities, and potentially improve their trading performance. But let's not forget that while watching smart money flow can provide valuable insights, it is crucial to incorporate effective risk management strategies to protect capital and mitigate potential losses. Employing a consistent and effective risk management plan helps traders navigate the uncertainties of the market in a more controlled and calculated manner, increasing the likelihood of long-term success
If you want to stay updated on the latest options trades for META,<a href="https://benzinga.grsm.io/register174"> Benzinga Pro</a> gives you real-time options trades alerts.&nbsp;
<a href="https://benzinga.com/apis?_gl=1&#x2A;1hlgn5i&#x2A;_ga&#x2A;MTY1NjE2NTYxMi4xNzE0NzQ4MTAy&#x2A;_ga_V7ZK73W7N0&#x2A;MTcxNDc0ODEwMi4xLjEuMTcxNDc0ODQyOC4wLjAuMA..">Market News and Data brought to you by Benzinga APIs</a> and include firms, like<a href="https://tradepulse.net/?utm_source=Benzinga&amp;utm_medium=Article&amp;utm_campaign=brand_awareness_June2025"> https://tradepulse.net/?utm_source=Benzinga&amp;utm_medium=Article&amp;utm_campaign=brand_awareness_June2025</a>, which are responsible for parts of the data within this article.
After Market Close UPDATE:
The price at the time of the Power Inflow was ($715.88). The returns on the High price ($728.18) and Close price ($726.09) after the Power Inflow are respectively 1.7% and 1.4%. The result underlines the importance of a trading plan that includes Profit Targets and Stop Losses that reflect your risk appetite.
Past performance is not indicative of future results

Equities

Technicals

Opinion

Signals

Meta Up 1.7% After Key Trading Signal Flashes Again This Week

<a href="https://www.reuters.com/legal/government/trump-plans-executive-orders-power-ai-growth-race-with-china-2025-06-27/" title="https://www.reuters.com/legal/government/trump-plans-executive-orders-power-ai-growth-race-with-china-2025-06-27/">https://www.reuters.com/legal/government/trump-plans-executive-orders-power-ai-growth-race-with-china-2025-06-27/</a>

OKLO

Reuters Reported Trump Administration Preparing Package Of Executive Orders To Boost Power Supplies For AI Industry

InMed Pharmaceuticals Closes $5M At-The-Market Private Placement With H.C. Wainwright As Placement Agent

Hannon Armstrong Sustainable Infrastructure Capital

HASI

HASI Raises Tender Offer Cap To $700M, Reports $920M In Early Tenders For Sustainable Infrastructure Notes

Amazon.com Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) founder Jeff Bezos and former journalist Lauren Sanchez kicked off their wedding celebrations Thursday in Venice, Italy, ahead of a weekend ceremony attended by a who's who of A-list guests. The multi-day affair, which began on June 26, has attracted celebrities from the worlds of entertainment, business and politics.
Here are some of the prominent names spotted by paparazzi on the opening day of the wedding weekend, according to Reuters.
<h3 class="wp-block-heading">Oprah Winfrey</h3>
The talk-show legend and OWN chair stepped off a private launch near Madonna dell'Orto church, adding daytime-TV star power to the evening welcome party.
<h3 class="wp-block-heading">Bill Gates</h3>
Microsoft's (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) co-founder arrived with partner Paula Hurd and mingled at the cloistered reception, a high-profile reunion for two of the world's richest men.
<h3 class="wp-block-heading">Kim Kardashian</h3>
The Skims entrepreneur brought reality-show glitz and several sisters to Venice, reuniting with Bezos after <a href="https://www.benzinga.com/general/entertainment/24/09/40860724/bezos-doesnt-sunbathe-alone-on-his-25m-a-year-superyacht-as-he-hosts-kim-kardashian-leonard">last summer's cruise</a> aboard his super-yacht Koru.
<h3 class="wp-block-heading">Leonardo DiCaprio</h3>
Fresh from the Cannes circuit, the Oscar winner slipped in for the festivities with model Vittoria Ceretti, highlighting Bezos' growing Hollywood circle.
See also: <a href="https://www.benzinga.com/news/entertainment/25/06/46107000/jeff-bezos-first-marriage-ended-in-a-38-billion-divorce-now-as-the-amazon-founder-plans-to-marry-lauren-sanchez-hes-reportedly-ring-fencing-his-233-billion-fortune">Jeff Bezos&#8217; First Marriage Ended In A $38 Billion Divorce — Now, As The Amazon Founder Plans To Marry Lauren Sanchez, He&#8217;s Reportedly Ring-Fencing His $233 Billion Fortune</a>
<h3 class="wp-block-heading">Tom Brady</h3>
The seven-time Super Bowl champ proved the dress code extends to sports royalty, trading cleats for a tux as he greeted fellow guests outside the Aman Canal Grande.
<h3 class="wp-block-heading">Queen Rania of Jordan</h3>
Royal elegance arrived via water taxi when Jordan's queen joined the party, highlighting the couple's expanding geopolitical rolodex.
<h3 class="wp-block-heading">Ivanka Trump</h3>
The former White House adviser toured Venice with her husband, Jared Kushner, before taking her seat among Silicon Valley heavyweights.
<h3 class="wp-block-heading">Andy Jassy</h3>
Amazon's current chief executive flew in from Seattle, signaling that corporate leadership stood firmly behind its founder on his big day.
Read next: <a href="https://www.benzinga.com/news/politics/25/06/46087635/bernie-sanders-slams-jeff-bezos-lavish-wedding-plans-demands-end-to-oligarchy-amazon-founder-pays-1-1-tax-takes-500-million-yacht-to-venice-while-kids-go-hungry" target="_blank" rel="noreferrer noopener">Bernie Sanders Slams Jeff Bezos' Lavish Wedding Plans, Demands ‘End' To Oligarchy: Amazon Founder Pays 1.1% Tax, Takes $500 Million Yacht To Venice While Kids Go Hungry</a>
Image Credit: Saul Loeb-Pool via Imagn Images

Entertainment

General

AMZN

MSFT

Jeff Bezos, Lauren Sanchez' Wedding Draws Star-Studded Guest List To Venice: Here Are The Celebs Who Showed Up So Far

Climb Channel Solutions, an international specialty technology distributor and wholly owned subsidiary of Climb Global Solutions, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLMB#NASDAQ">CLMB</a>) is proud to announce a distribution agreement with Egnyte, a leader in secure content collaboration, intelligence, and governance.
This partnership enables Climb to deliver Egnyte's cloud-native platform to partners and their customers across the United States, reinforcing Climb's commitment to expanding access to transformative technologies worldwide. By adding Egnyte to its portfolio, Climb is equipping resellers with a trusted, scalable platform that fits seamlessly into both SMB and enterprise environments. This partnership underscores Climb's mission to deliver partner-first technologies that move with the speed of modern business.

CLMB

Climb Channel Teams Up With Egnyte to Bring Secure Cloud Collaboration Tools to US Businesses

TNGX

Tango Therapeutics Doses First Patient In Phase 1/2 Combo Trial With Revolution Medicines' RAS Inhibitors For MTAP-Deleted Cancers

Gencor Granted NYSE American Extension To Regain Listing Compliance By August 19, 2025

Bone Biologics Files USPTO Patent For rhNELL-1 Protein In Bone Regeneration Therapy

Webuy Global Ltd. (NASDAQ:<a href="https://www.benzinga.com/stock/WBUY#NASDAQ">WBUY</a>) ("Webuy" or the "Company"), a fast-growing Southeast Asian e-commerce and travel technology company, has entered into a strategic Memorandum of Understanding (MOU) with CTG MICE Service Company Limited.("CTG MICE"), a subsidiary of China Tourism Group Travel Services Co. Ltd., which is part of China Tourism Group Corporation Limited ("CTG"), the largest state-owned tourism enterprise in China. The partnership aims to jointly develop and scale inbound tourism services to China.
Under this landmark partnership, both companies will jointly facilitate the annual arrival of at least 20,000 Chinese inbound travelers by enhancing infrastructure, designing curated travel routes, and delivering premium VIP services. By leveraging AI-powered itinerary planning, real-time support, and seamless travel experiences, the collaboration seeks to position China as a premier global destination for cultural tourism.

WBUY

Webuy Teams Up With China Tourism Giant to Bring 20,000 Travelers to China Annually

HC Wainwright &amp; Co. analyst Amit Dayal maintains Orion Energy Sys (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OESX#NASDAQ">OESX</a>) with a Buy and lowers the price target from $3 to $2.

OESX

HC Wainwright & Co. Maintains Buy on Orion Energy Sys, Lowers Price Target to $2

<ul>
<li>Neopharmed Gentili will pay BioCryst $250 million upfront for the European assets and rights related to ORLADEYO, and up to $14 million in future milestones.</li>
<li>BioCryst plans to use proceeds to retire all remaining term debt, which will eliminate approximately $70 million of future interest payments over remaining life of the loan.</li>
<li>With this transaction, BioCryst expects to end 2027 with approximately $700 million in cash and no term debt (an increase of $400 million from prior 2027 net cash guidance)</li>
</ul>

Biotech

Health Care

BCRX

BioCryst Pharmaceuticals Agrees To Sell Its European Orladeyo (Berotralstat) Business To Neopharmed Gentili For Up To $264M

Press Releases

Eupraxia's DiffuSphere™ Technology Demonstrates Targeted Drug Release while Minimizing Systemic Exposure for a Period of More Than Six Months

Eupraxia Pharmaceuticals Announces CFO Succession

Eupraxia Pharmaceuticals Announces Positive Data from RESOLVE Phase 1b/2a Trial of EP-104GI for Treatment of Eosinophilic Esophagitis

Eupraxia Pharmaceuticals Reports Fourth Quarter 2024 Financial Results

Eupraxia Pharmaceuticals to Present at Investor and Scientific Conferences in April and May

Eupraxia Pharmaceuticals Announces Sustained Positive Treatment Outcomes in Patients with Eosinophilic Esophagitis (EoE) After Nine Months of Receiving EP-104GI

Eupraxia Pharmaceuticals Reports First Quarter 2025 Financial Results

Eupraxia Pharmaceuticals to Host Virtual KOL Event to Discuss the Phase 1b/2a RESOLVE Study of EP-104GI for the Treatment of Eosinophilic Esophagitis (EoE) on May 9, 2025

Comments

Eupraxia Pharmaceuticals

ニュース

最新ニュース Eupraxia Pharmaceuticals (NASDAQ:EPRX) 株価情報

ニュース

パートナーシップ

ベンジンガ・グローバル